FDA approves Leqembi home administration. Learn about the new starting dosage regimen for subcutaneous lecanemab...
Learn why bispecific T-cell therapy for multiple myeloma may face access restrictions and how patient...
A groundbreaking drug for resistant hypertension offers hope to patients unresponsive to standard treatments, targeting...
Menin inhibitors offer new hope for AML treatment by targeting molecular drivers in 40% of...